{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:01:51Z","timestamp":1787022111280,"version":"build-2736575974"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T00:00:00Z","timestamp":1664236800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000724","name":"Health Foundation","doi-asserted-by":"publisher","award":["Funded SHAREHD study"],"award-info":[{"award-number":["Funded SHAREHD study"]}],"id":[{"id":"10.13039\/501100000724","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Haemodialysis patients experience significant symptom burden and effects on health-related quality of life. Studies have shown increases in fluid overload, hospitalization and mortality immediately after the long interdialytic interval in thrice weekly in-centre haemodialysis patients, however the relationship between the dialytic interval and patient reported outcome measures (PROMs) has not been quantified and the extent to which dialysis day of PROM completion needs to be standardised is unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Three times a week haemodialysis patients participating in a stepped wedge trial to increase patient participation in haemodialysis tasks completed PROMs (POS-S Renal symptom score and EQ-5D-5L) at recruitment, six, 12 and 18 months. Time from the long interdialytic interval, HD day of the week, and HD days vs non-HD days were included in mixed effects Linear Regression, estimating severity (none to overwhelming treated as 0 to 4) of 17 symptoms and EQ-5D-5L, adjusting for age, sex, time on HD, control versus intervention and Charlson Comorbidity Score.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>517 patients completed 1659 YHS questionnaires that could be assigned HD day (510 on Mon\/Tue\/Sun, 549 on Wed\/Thu\/Tue, 308 on Fri\/Sat\/Thu and 269 on non-HD days). With the exception of restless legs and skin changes, there was no statistically significant change in symptom severity or EQ-5D-5L with increasing time from the long interdialytic interval. Patients who responded on non-HD days had higher severity of poor appetite, constipation, difficulty sleeping, poor mobility and depression (approximately 0.2 severity level), and lower EQ-5D-5L (-0.06, CI -0.09 to -0.03) compared to HD days.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Measuring symptom severity and EQ-5D-5L in haemodialysis populations does not need to account for dialysis schedule, but completion either on HD or non-HD days could introduce bias that may impact evaluation of interventions. Researchers should ensure completion of these instruments are standardized on either dialysis or non-dialysis days.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0274599","type":"journal-article","created":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T13:32:41Z","timestamp":1664285561000},"page":"e0274599","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Symptom burden according to dialysis day of the week in three times a week haemodialysis patients"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4856-2681","authenticated-orcid":true,"given":"Pann Ei","family":"Hnynn Si","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Gair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louese","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Ariss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Walters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1059-6453","authenticated-orcid":true,"given":"Martin","family":"Wilkie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Fotheringham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,9,27]]},"reference":[{"issue":"1","key":"pone.0274599.ref001","doi-asserted-by":"crossref","DOI":"10.1186\/s12882-017-0638-y","article-title":"Symptom burden in chronic kidney disease; A population based cross sectional study","volume":"18","author":"S. Senanayake","year":"2017","journal-title":"BMC Nephrol."},{"issue":"1","key":"pone.0274599.ref002","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1053\/j.ajkd.2017.12.018","article-title":"Establishing a Core Outcome Measure for Fatigue in Patients on Hemodialysis: A Standardized Outcomes in Nephrology\u2013Hemodialysis (SONG-HD) Consensus Workshop Report","volume":"72","author":"A. Ju","year":"2018","journal-title":"American Journal of Kidney Diseases"},{"issue":"3","key":"pone.0274599.ref003","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4081\/hpr.2013.932","article-title":"Quality of life in chronic disease patients","volume":"1","author":"K. Megari","year":"2013","journal-title":"Heal. Psychol. Res."},{"issue":"SUPPL. 2","key":"pone.0274599.ref004","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0272-6386(04)01106-0","article-title":"Health-related quality of life in the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"44","author":"D. L. Mapes","year":"2004","journal-title":"Am. J. Kidney Dis."},{"issue":"3","key":"pone.0274599.ref005","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jpainsymman.2003.07.004","article-title":"Development of a symptom assessment instrument for chronic hemodialysis patients: The dialysis symptom index","volume":"27","author":"S. D. Weisbord","year":"2004","journal-title":"J. Pain Symptom Manage."},{"issue":"12","key":"pone.0274599.ref006","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1089\/jpm.2013.0176","article-title":"Improving symptom management in hemodialysis patients: Identifying barriers and future directions","volume":"16","author":"R. Feldman","year":"2013","journal-title":"J. Palliat. Med."},{"issue":"1","key":"pone.0274599.ref007","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/0825859719827315","article-title":"Changes in Symptom Burden in Dialysis Patients Assessed Using a Symptom-Reporting Questionnaire in Clinic","volume":"35","author":"J. T. Moskovitch","year":"2020","journal-title":"J. Palliat. Care"},{"issue":"Supplement_1","key":"pone.0274599.ref008","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfz096.FO031","article-title":"FO031THE SYMPTOM MONITORING WITH FEEDBACK TRIAL (SWIFT): A NOVEL REGISTRY-BASED CLUSTER RANDOMISED CONTROLLED TRIAL AMONG AUSTRALIAN AND NEW ZEALAND ADULTS WITH END-STAGE KIDNEY DISEASE MANAGED ON HAEMODIALYSIS","volume":"34","author":"R. Morton","year":"2019","journal-title":"Nephrol. Dial. Transplant."},{"issue":"2","key":"pone.0274599.ref009","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/ckj\/sfaa250","article-title":"Survival on four compared with three times per week haemodialysis in high ultrafiltration patients: an observational study","volume":"14","author":"J. Fotheringham","year":"2021","journal-title":"Clin. Kidney J."},{"issue":"12","key":"pone.0274599.ref010","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJMoa1103313","article-title":"Long Interdialytic Interval and Mortality among Patients Receiving Hemodialysis","volume":"365","author":"R. N. Foley","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"pone.0274599.ref011","doi-asserted-by":"crossref","first-page":"308","DOI":"10.5527\/wjn.v3.i4.308","article-title":"Quality of life in end stage renal disease patients","volume":"3","author":"V. D. Joshi","year":"2014","journal-title":"World J. Nephrol."},{"issue":"3","key":"pone.0274599.ref012","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1016\/j.ekir.2020.02.239","article-title":"SAT-224 THE IMPACT OF DEPRESSION AND ANXIETY ON QUALITY OF LIFE OF END-STAGE RENAL DISEASE PATIENTS ON HEMODIALYSIS TREATMENT: A LITERATURE REVIEW","volume":"5","author":"M. AYORINDE","year":"2020","journal-title":"Kidney Int. Reports"},{"issue":"10","key":"pone.0274599.ref013","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1002\/hed.24875","article-title":"Symptom burden and patient characteristics: Association with quality of life in patients with head and neck cancer undergoing radiotherapy","volume":"39","author":"G. L. Astrup","year":"2017","journal-title":"Head Neck"},{"issue":"1","key":"pone.0274599.ref014","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0272-6386(03)00415-3","article-title":"Adapting the Charlson comorbidity index for use in patients with ESRD","volume":"42","author":"B. R. Hemmelgarn","year":"2003","journal-title":"Am. J. Kidney Dis."},{"issue":"1","key":"pone.0274599.ref015","first-page":"1","article-title":"Mortality and health-related quality of life in prevalent dialysis patients: Comparison between 12-items and 36-items short-form health survey","volume":"10","author":"T. B. H. \u00d8sthus","year":"2012","journal-title":"Health Qual. Life Outcomes"},{"issue":"1","key":"pone.0274599.ref016","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s12882-017-0748-6","article-title":"Rationale and design for SHAREHD: A quality improvement collaborative to scale up Shared Haemodialysis Care for patients on centre based haemodialysis","volume":"18","author":"J. Fotheringham","year":"2017","journal-title":"BMC Nephrol."},{"issue":"7","key":"pone.0274599.ref017","doi-asserted-by":"crossref","first-page":"e0253966","DOI":"10.1371\/journal.pone.0253966","article-title":"A breakthrough series collaborative to increase patient participation with hemodialysis tasks: A stepped wedge cluster randomised controlled trial","volume":"16","author":"J. Fotheringham","year":"2021","journal-title":"PLoS One"},{"key":"pone.0274599.ref018","unstructured":"\u201cPalliative care Outcome Scale (POS)\u2014IPOS-Renal and translations.\u201d https:\/\/pos-pal.org\/maix\/ipos-renal-in-english.php (accessed Mar. 11, 2021)."},{"issue":"10","key":"pone.0274599.ref019","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","article-title":"Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)","volume":"20","author":"M. Herdman","year":"2011","journal-title":"Qual. Life Res."},{"issue":"11","key":"pone.0274599.ref020","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"H. Quan","year":"2005","journal-title":"Med. Care"},{"key":"pone.0274599.ref021","first-page":"268","article-title":"How to Design, Analyse and Report Cluster Randomised Trials in Medicine and Health Related Research.","author":"M. J. Campbell","year":"2014"},{"key":"pone.0274599.ref022","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000504851","article-title":"The 21st UK Renal Registry Annual Report: A Summary of Analyses of Adult Data in 2017","volume":"144","author":"R. Pyart","year":"2020","journal-title":"Nephron"},{"key":"pone.0274599.ref023","article-title":"Valuing Individuals: Transforming Participation in Chronic Kidney Disease Patient Activation Measure-Patient Reported Outcome Measure Report Cohort 1","author":"R. Gair","year":"2016"},{"issue":"1","key":"pone.0274599.ref024","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/j.ackd.2006.10.001","article-title":"The Prevalence of Symptoms in End-Stage Renal Disease: A Systematic Review","volume":"14","author":"F. E. M. Murtagh","year":"2007","journal-title":"Adv. Chronic Kidney Dis."},{"issue":"2","key":"pone.0274599.ref025","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jclinepi.2007.03.012","article-title":"Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes","volume":"61","author":"D. Revicki","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"issue":"6","key":"pone.0274599.ref026","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s11136-004-7713-0","article-title":"Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D","volume":"14","author":"S. J. Walters","year":"2005","journal-title":"Qual. Life Res."},{"issue":"8","key":"pone.0274599.ref027","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.neurobiolaging.2010.04.011","article-title":"Reduced sample sizes for atrophy outcomes in Alzheimer\u2019s disease trials: Baseline adjustment","volume":"31","author":"J. M. Schott","year":"2010","journal-title":"Neurobiol. Aging"},{"issue":"5","key":"pone.0274599.ref028","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jclinepi.2003.09.014","article-title":"Covariate adjustment in randomized controlled trials with dichotomous outcomes increases statistical power and reduces sample size requirements","volume":"57","author":"A. V. Hern\u00e1ndez","year":"2004","journal-title":"J. Clin. Epidemiol."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0274599","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T13:33:06Z","timestamp":1664285586000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0274599"}},"subtitle":[],"editor":[{"given":"Gianpaolo","family":"Reboldi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,9,27]]},"references-count":28,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0274599","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,27]]}}}